Keywords: خطر ترومبوتیک; ADMA; asymmetric dimethylarginine; AF; atrial fibrillation; CHA2DS2-VASc score; congestive heart failure, hypertension, age â¥75 (doubled), diabetes, stroke (doubled), vascular disease, age 65-74, sex category (female); ECG; electrocardiography; LA; le
مقالات ISI خطر ترومبوتیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Fibrilación auricular y flúter auricular
Keywords: خطر ترومبوتیک; Fibrilación auricular; Flúter auricular; Riesgo trombótico; Nuevos anticoagulantes orales; Ablación con radiofrecuencia; Atrial fibrillation; Atrial Flutter; Thrombotic risk; New oral anticoagulants; Ablation with radiofrequency;
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
Keywords: خطر ترومبوتیک; anticoagulation; atrial fibrillation; bleeding risk; bridging; direct-acting anticoagulants; surgical procedures; thrombotic risk; warfarin;
Prophylaxie de la maladie thromboembolique veineuse chez les patients à risque hospitalisés en Algérie : étude PROMET
Keywords: خطر ترومبوتیک; Risque thrombotique; Risque hémorragique; Thromboprophylaxie; Thrombotic risk; Hemorrhagic risk; Thromboprophylaxis;
Biochemical characterization of prothrombin complex concentrates in China
Keywords: خطر ترومبوتیک; Prothrombin complex concentrates; Coagulation factor; Coagulation inhibitor; Thrombin inhibitory capacity; Specific activity; Thrombotic risk; PCCs; prothrombin complex concentrates; Fâ
¡; factor â
¡; Fâ
¦; factor â
¦; Fâ
¨; factor â
¨; Fâ
©; factor â
©;
Enquête d'opinions sur la pratique de la ponction lombaire non urgente chez des patients à risque hémorragiques/thrombotiques
Keywords: خطر ترومبوتیک; Ponction lombaire; Risque hémorragique; Risque thrombotique; Anticoagulatants; Antiagrégants plaquettaires; Trouble de la coagulation; Lombar puncture; Haemorrhagic risk; Thrombotic risk; Anticoagulant; Antiplatelet; Coagulation disorders;
Flebogamma® DIF (intravenous immunoglobulin) purification process effectively eliminates procoagulant activities
Keywords: خطر ترومبوتیک; Procoagulant activity; Intravenous immunoglobulin; Activated coagulation factor XI; Purification process; Flebogamma® DIF; Thrombotic risk
Multistability in platelets and their response to gold nanoparticles
Keywords: خطر ترومبوتیک; Gold nanoparticle; Multi-stability; Granule release; Adhesion; Activation; Nanosafety measure; Thrombotic risk
Platelet response as a sentinel marker of toll-like receptor 4 activation in mice
Keywords: خطر ترومبوتیک; TLR4; toll-like receptor 4; dTLR4; deletion of TLR4; LPS; lipopolysaccharide; TNFα; tumor necrosis factor alpha; WT; wild type mice; glycoprotein IIIa; CD61; PE; Phycoerythrin; FITC; fluorescein isothiocynate; SA-PE; streptavidin-PE; Infection; Inflammat
Contraccezione ormonale e rischio tromboembolico: dalle raccomandazioni della Regione Piemonte alla conferenza di consenso dell'Istituto Superiore di SanitÃ
Keywords: خطر ترومبوتیک; Hormonal contraception; Thrombotic risk; Venous thromboembolism; Thrombophilia;
Anesthésie locorégionale et anti-agrégants plaquettaires : le jeu en vaut-il la chandelle ?
Keywords: خطر ترومبوتیک; Anti-agrégant plaquettaire; Anesthésie locorégionale; Complications postopératoires; Risque hémorragique; Antiplatelet agents; Regional anaesthesia; Postoperative outcome; Haemorrhagic risk; Thrombotic risk;
Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
Keywords: خطر ترومبوتیک; FV Leiden; Factor V Leiden; proCPU; procarboxypeptidase U; CPU; carboxypeptidase U; TAFI; Thrombin Activatable Fibrinolysis Inhibitor; TAFIa; activated Thrombin Activatable Fibrinolysis Inhibitor; IIa; thrombin; TM; thrombomodulin; PPACK; D-phenylalanyl-L
The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk
Keywords: خطر ترومبوتیک; Thrombotic risk; PAI-1; 4G/5G polymorphism